We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nanoparticle Ionic Silver Antimicrobial Coating

By HospiMedica staff writers
Posted on 29 Dec 2005
A breakthrough nanoparticle treatment can render medical devices antimicrobial, dramatically reducing hospital-related infections.

The first product based on this novel technology to receive clearance by the U.S. More...
Food and Drug Administration (FDA) is the ON-Q SilverSoaker regional anesthesia delivery catheter, manufactured by I-Flow (Lake Forest, CA, USA). The ON-Q SilverSoaker catheters are treated with SilvaGard, a silver nanoparticle antimicrobial coating that protects against the formation of infection-causing biofilm. Other applications include surgical tools and titanium implants.

SilvaGard nanotechnology, developed by AcryMed (Portland, OR, USA) provides an easy, cost-effective way to apply a surface treatment of ionic silver, long recognized and used as an antimicrobial substance. Treated devices can provide effective antimicrobial protection for days, weeks, or even months, depending upon application requirements. SilvaGard can be used to treat virtually any medical device and its use does not alter the device's original properties. Due to these and other unique attributes, SilvaGard is expected to have a significant impact on the battle against hospital-related infections.

"We are excited to be the first company to gain FDA clearance for the use of this breakthrough antimicrobial technology, specifically in our unique ON-Q SilverSoaker” said Donald M. Earhart, chairman, president and CEO of I-Flow.

Development talks are being held with other device manufacturers who have approached AcryMed about using SilvaGard for the treatment of their devices, stated Jack D. McMaken, president and CEO of AcryMed.

According to the U.S. Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA), 1 in 20 patients in hospitals in the United States contract an infection not associated with their original diagnosis. The overwhelming cases of these hospital infections come from medical devices such as catheters, IV tubes, and hip implants, where bacteria can attach and spread.





Related Links:
I-Flow
AcryMed

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.